M.M. - Pharma SPRL
M.M. - Pharma reported total assets of 261,456 € at the end of the 2024 financial year (annual accounts filed with the NBB on 27 Sep 2025).
The score of M.M. - Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Equity +3 % Total assets -2 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
M.M. - Pharma's annual accounts
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Net result | −15,112 € | ||||
| Equity | 199,976 € | ||||
| Cash | 254,012 € | ||||
| EBITDA | −12,512 € | ||||
| Total assets | 261,456 € |
Filed annual accounts
- Year ended 31 Dec 2024filed on 27 Sep 2025
- Year ended 31 Dec 2023filed on 28 Sep 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 28 Jul 2022
- Year ended 31 Dec 2020filed on 31 Aug 2021
M.M. - Pharma's financial analysis
- Solvency76.5%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of M.M. - Pharma
M.M. - Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0435.999.063
- VAT number
- BE0435999063
- Peppol
- Registered · 0208:0435999063 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 15 Nov 1988
- Registered office
- 1000 Brussels
- Latest accounts
- 2024 · filed on 27 Sep 2025
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
M.M. - Pharma (SPRL) has been based in Brussels since 1988, active in: retail sale of pharmaceutical products. For 2024, it reports a net loss of 15,112 € and equity of 199,976 €; its revenue is not published. Its solvency stands at 76.5%, above the median of its sector (37.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to M.M. - Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Coloniale Retail sale of pharmaceutical products Ixelles · balance sheet 261,567 €
- Apotheek Delendeker Retail sale of pharmaceutical products Leuven · balance sheet 261,811 €
- Atouphar Retail sale of pharmaceutical products Flémalle · balance sheet 260,410 €
- Apoteek Brichau Retail sale of pharmaceutical products Halle · balance sheet 263,690 €
- Apotheca Retail sale of pharmaceutical products Saint-Josse-ten-Noode · balance sheet 258,897 €
- Linda Pharma Retail sale of pharmaceutical products Etterbeek · balance sheet 258,710 €
- Yasmin Libbrecht Retail sale of pharmaceutical products Antwerp · balance sheet 258,250 €
- Pharmadeville Retail sale of pharmaceutical products Bernissart · balance sheet 257,934 €
Frequently asked questions about M.M. - Pharma
What is the revenue of M.M. - Pharma?
M.M. - Pharma files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of M.M. - Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0435999063 for M.M. - Pharma, if the company is VAT-registered. Its company number (CBE) is 0435.999.063.
Where is the registered office of M.M. - Pharma?
According to the CBE register, the registered office of M.M. - Pharma is in 1000 Brussels.
What is the equity of M.M. - Pharma?
At the close of the 2024 financial year, the equity of M.M. - Pharma amounts to 199,976 €, a solvency of 76.5% of total assets.
Who manages M.M. - Pharma?
The register lists 2 active mandates at M.M. - Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of M.M. - Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →